Posted on January 29, 20201/29/20
Country: UNITED STATES | Region: NORTH AMERICA | Type: Policy | Keywords: #clinicaldevelopment #fda #genetherapy #guidance PRICENTRIC BRIEF: The Food and Drug Administration has approved 4 gene therapy products thus far, and anticipates many more approvals in the coming years, as evidenced by the more than 900 investigational new drug (IND) applications for ongoing clinical studies in this area To support the continued development of gene therapies, […]
Posted on January 27, 20201/27/20
Country: IRELAND | Region: EUROPE | Type: Policy | Keywords: #hse #ipha #newmedicinespolicy #patientaccess #pricingandreimbursement #sustainability PRICENTRIC BRIEF: The Irish Pharmaceutical Healthcare Association (IPHA), the representative body of the international originator biopharmaceutical industry in Ireland, has urged all political parties to pledge to improve patients’ access to new medicines as part of their plans for health during general elections Ireland is among the slowest in Western Europe to provide […]
Posted on January 23, 20201/23/20
EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, CA, and CHICAGO, IL. January 23, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, an independent provider of global commercial services […]
Posted on January 21, 20201/21/20
PurchaseCountry: CHINA | Region: ASIA & SOUTH PACIFIC | Type: Regulation | Keywords: #bmi #drugpurchase #nhsa #pricereductions #shanghaidrugpurchasenetwork #tender PRICENTRIC BRIEF: The Shanghai Drug Purchase Network, the National Health Security Administration’s (NHSA) executive for Round 2 of the National Level Centralized Drug Purchase Program, announced that Round 2 includes the purchase of 33 drugs regarding 50 specifications According to Chinese media, the average price reduction by prevailing suppliers […]
Posted on January 21, 20201/21/20
Today’s patients are far more engaged than the previous era of “doctor knows best.” Powered by the technology they use in their daily lives, the patient community is partnering with providers, scientists, regulators, disease state experts, and manufacturers to: Design clinically meaningful endpoints Engage and educate online communities Improve disease awareness and diagnosis Co-design patient […]
Posted on January 13, 20201/13/20
More than 2000 executives interested in driving innovation in clinical trials and digital health will be gathered at the 11th annual SCOPE Summit for Clinical Ops Executives, held this year from February 18-21 in Orlando, FL. The four-day conference will cover in-depth discussions across 20 different conferences, feature 3 plenary keynote sessions and interactive breakout […]
Posted on January 9, 20201/9/20
Take the Digital Therapies Commercialization Quiz. Can your organization answer the top 10 questions required to avoid pitfalls and navigate the uniquely complicated and regulated healthcare market? Will someone (payer or patient) pay for my product? How are payers thinking about my disease? Who pays for this disease today? What’s the right business model and […]
Posted on January 9, 20201/9/20
CHICAGO – January 9, 2020 – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, and Noom, the world’s leading behavior change company, today announced a collaboration to increase medication adherence and improve health outcomes for the millions of patients suffering from chronic conditions and rare diseases worldwide. The partnership combines […]
Posted on January 8, 20201/8/20
Country: LUXEMBOURG | Region: EUROPE | Type: Regulation | Keywords: #almps #drugsafety #drugshortages #medicinesagency PRICENTRIC BRIEF: Since Luxembourg is currently one of the only European countries not to have a National Medicines and Health Products Agency, the Government Council approved a bill establishing the Luxembourg Agency for Medicines and Health Products (ALMPS) to oversee competences in the field of drugs, medical devices, and other health products such […]
Posted on January 7, 20201/7/20
CHICAGO – January 7, 2020 – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today unveiled EVERSANA ENGAGE, the full-solution healthcare marketing agency uniquely designed to help pharmaceutical and biotechnology companies cohesively reach patients, providers and payers to enhance the patient experience and improve outcomes. EVERSANA ENGAGE combines EVERSANA’s market […]
